Low dose vasopressin given during liver transplantation prevents renal dysfunction in the perioperative period confirmed by evaluating creatinine postoperatively. baseline, 24 hours postop, 48 hours postop [clinicaltrials_resource:abeec3b8e64c46c929c69c8a5b1febae]
Patients randomly assigned to the experimental arm of the study will receive vasopressin 0.5U/hr IV (20 U vasopressin in 250mL of 0.9% NaCL to infuse at a rate of 6.25mL/hr) via internal jugular catheter. Vasopressin infusion is started at the time of incision and is stopped at the time abdominal closure is completed
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Low dose vasopressin given during liver transplantation prevents renal dysfunction in the perioperative period confirmed by evaluating creatinine postoperatively. baseline, 24 hours postop, 48 hours postop [clinicaltrials_resource:abeec3b8e64c46c929c69c8a5b1febae]
Patients randomly assigned to the experimental arm of the study will receive vasopressin 0.5U/hr IV (20 U vasopressin in 250mL of 0.9% NaCL to infuse at a rate of 6.25mL/hr) via internal jugular catheter. Vasopressin infusion is started at the time of incision and is stopped at the time abdominal closure is completed
Bio2RDF identifier
abeec3b8e64c46c929c69c8a5b1febae
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:abeec3b8e64c46c929c69c8a5b1febae
measure [clinicaltrials_vocabulary:measure]
Low dose vasopressin given dur ...... ng creatinine postoperatively.
time frame [clinicaltrials_vocabulary:time-frame]
baseline, 24 hours postop, 48 hours postop
description
Patients randomly assigned to ...... abdominal closure is completed
identifier
clinicaltrials_resource:abeec3b8e64c46c929c69c8a5b1febae
title
Low dose vasopressin given dur ...... hours postop, 48 hours postop
@en
type
label
Low dose vasopressin given dur ...... ec3b8e64c46c929c69c8a5b1febae]
@en